stalled for 15 weeks at 1.7mg and I refuse to panic this time
stalled for 15 weeks at 1.7mg and I refuse to panic this time. It is the sort of thing everyone half-believes and nobody writes down.
The numbers the title promised, since a headline without them is worthless: 15 weeks and 1.7mg. Everything below is context for those.
Added ApoB to the panel after a thread here. It told me something the standard lipid panel had been hiding.
Compared two draws across two labs and spent a week worrying before finding out the assays were different.
Tell me where this is wrong. That is the useful part of posting it.
best — the order this archive was captured in
The confounding problem, stated plainly, because this board keeps stepping on it.
Substantial weight loss moves lipids, liver enzymes, insulin sensitivity markers and several others in its own right. If you are losing weight while taking something, any change in those markers has at least two candidate explanations and you cannot separate them from your own panel.
What you can do is standardise, take a baseline, keep the series long, and be honest in your posts about what is and is not attributable. The threads that say "this compound did X to my triglycerides" almost never have the design to support the claim, mine included.
hydration status moves a surprising number of markers
Different laboratories use different assay platforms with different calibration. Comparing across labs adds a systematic offset that is invisible on the report.
the trend line matters more than any single value
same lab, same conditions, or you are comparing noise
How many weeks between the two measurements?
That is a non-fasting value and the interval you are comparing it against is a fasting one.
Not convinced by the attribution. Weight loss alone moves that marker and you have no way to separate the two.